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Rab11Megalencephalic leukoencephalopathy with subcortical cysts (MLC) is a rare leukodystrophy caused by
mutations in the gene encodingMLC1, amembrane proteinmainly expressed in astrocytes in the central nervous
system. Although MLC1 function is unknown, evidence is emerging that it may regulate ion ﬂuxes. Using bio-
chemical and proteomic approaches to identify MLC1 interactors and elucidate MLC1 function we found that
MLC1 interactswith the vacuolar ATPase (V-ATPase), the proton pump that regulates endosomal acidity. Because
we previously showed that in intracellular organelles MLC1 directly binds Na, K-ATPase, which controls
endosomal pH, we studied MLC1 endosomal localization and trafﬁcking and MLC1 effects on endosomal acidity
and function using human astrocytoma cells overexpressingwild-type (WT)MLC1 orMLC1 carrying pathological
mutations. We found that WT MLC1 is abundantly expressed in early (EEA1+, Rab5+) and recycling (Rab11+)
endosomes and uses the latter compartment to trafﬁc to the plasma membrane during hyposmotic stress. We
also showed that WT MLC1 limits early endosomal acidiﬁcation and inﬂuences protein trafﬁcking in astrocytoma
cells by stimulating protein recycling, as revealed by FITC-dextran measurement of endosomal pH and transferrin
protein recycling assay, respectively. WT MLC1 also favors recycling to the plasma-membrane of the TRPV4 cation
channel which cooperates with MLC1 to activate calcium inﬂux in astrocytes during hyposmotic stress. Although
MLC disease-causing mutations differentially affect MLC1 localization and trafﬁcking, all the mutated proteins fail
to inﬂuence endosomal pH and protein recycling. This study demonstrates that MLC1 modulates endosomal pH
and protein trafﬁcking suggesting that alteration of these processes contributes to MLC pathogenesis.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).(M.S. Brignone),
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. This is an open access article underIntroduction
Megalencephalic leukoencephalopathy with subcortical cysts
(MLC, OMIM 604004) is a rare congenital and incurable leukodystro-
phy characterised by early-onsetmacrocephaly, ataxia, seizures, degen-
eration of motor functions and mild cognitive decline. Magnetic
resonance imaging (MRI) indicates diffuse signal abnormality, swollen
appearance of the white matter and the presence of subcortical cysts
(Singhal et al., 2003; Topku et al., 1998; Van der Knaap et al., 1995a,
b). MLC patients have a slowly progressive clinical course that can be
worsened by minor head trauma and fever (Ben-Zeev et al., 2001;
Bugiani et al., 2003; Riel-Romero et al., 2005). Histopathological analy-
sis of MLC patient brains revealed intramyelinic vacuole formation,the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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(Van der Knaap et al., 1995a,b, 1996). Enlarged intracellular vacuoles
localized in the astrocyte end-feet contacting blood vessels have
also been described (Duarri et al., 2011).
Almost 75% of MLC patients carry different types of mutations in the
MLC1 gene suggesting that functional alterations of the MLC1 gene
product are the leading cause of this disease. However, to date no
correlation between genotype and phenotype has been found
(Leegwater et al., 2001, 2002; Patrono et al., 2003). Recently, muta-
tions in the HEPACAM/GLIALCAM gene encoding an adhesion-likemole-
cule of unknown function have been found in a substantial fraction of
MLC affected patients without MLC1 mutations, unveiling genetic
heterogeneity of MLC disease (Boor et al., 2006; Jeworutzki et al.,
2012; López-Hernández et al., 2011).
The MLC1 gene encodes an oligomeric and highly hydrophobic
protein which shows low homology with some ion channels and trans-
porters (Boor et al., 2005; Leegwater et al., 2001; Teijido et al., 2004). In
the central nervous system (CNS), MLC1 is mainly expressed in
perivascular and subpial astrocytes, particularly in astrocytic end-feet
contacting blood vessels and meninges (glia limitans) and in astrocytic
intracellular organelles (Ambrosini et al., 2008; Boor et al., 2007; Duarri
et al., 2011; Teijido et al., 2004). Bergmann glia and ependymal cells
lining the ventricles also express MLC1 (Ambrosini et al., 2008; Boor
et al., 2007; Duarri et al., 2008; Teijido et al., 2004). Outside the CNS,
MLC1 has been detected in monocytes and lymphocytes (Boor et al.,
2005; Duarri et al., 2008). Although myelin vacuolation is a typical fea-
ture of MLC disease, the myelin forming cells, oligodendrocytes, do not
express MLC1 (Boor et al., 2005; Schmitt et al., 2003), suggesting that
myelin degeneration may be secondary to astrocyte dysfunction.
Indeed, the tissue distribution and structural features of MLC1 protein
and MLC-associated brain damage suggest a possible role for MLC1 in
the regulation of ﬂuid and/or ion homeostasis, a function that in the
CNS is mainly carried out by astrocytes (Parpura and Verkhratsky,
2012). Consistent with this hypothesis, we have shown recently that
MLC1 is part of a macromolecular complex associated to the sodium,
potassium-ATPase pump (Na, K-ATPase) which includes the inward
rectiﬁer potassium channel 4.1 (Kir4.1), the water channel aquaporin-
4 (AQP4), the transient receptor potential cation channel subfamily V,
member 4 (TRPV4), the cytoskeletal anchoring protein syntrophin and
the membrane raft-associated protein caveolin-1 (Brignone et al.,
2011; Lanciotti et al., 2012). We have also provided evidence that
MLC1 is involved in the astrocytic response to changes in the extracellu-
lar ion composition and cooperates with TRPV4 to activate intracellular
calcium inﬂux during hyposmotic stress (Lanciotti et al., 2012). Most
importantly, we have found that these interactions and pathways are
affected by MLC1 pathological mutations (Lanciotti et al., 2012). The
TRPV4-mediated calcium inﬂux is the ﬁrst and essential step required
for the activation of astrocyte regulatory volume decrease (RVD)
which is needed to rescue the rapid and temporary cell swelling
induced by hyposmosis (Benfenati et al., 2007, 2011). Interestingly,
defects in a RVD-induced chloride current have been noted in rat
astrocytes following siRNA-mediated MLC1 downregulation and in
MLC patient-derived lymphoblasts (Ridder et al., 2011). Altogether,
these results support the hypothesis that MLC1 is an ion channel
involved in the astrocyte response to osmotic imbalance and regu-
lation of cell volume.
In initial experiments aimed at identifying MLC1 protein interactors
and MLC1-associated functional pathways, we found that MLC1 inter-
acts with the vacuolar ATPase (V-ATPase), the proton pump responsible
for endosomal acidiﬁcation (Forgac, 2007). This ﬁnding and the obser-
vation that in rat primary astrocytes and human astrocytoma cells
MLC1 binds the Na, K-ATPase which, among other functions, controls
early endosomal pH (Brignone et al., 2011; Lanciotti et al., 2012),
prompted us to investigate the possible role of MLC1 in organelle acid-
iﬁcation and protein trafﬁcking and the effects of MLC disease-
associated pathological mutations on these pathways.Materials and methods
Cell cultures and treatments
Astrocyte-enriched cultures (about 95% purity) were generated
from 1- or 2-day-old newborn rats and maintained in culture as previ-
ously described (Agresti et al., 1991). By using a retroviral bicistronic
vector (pQCXIN, Takara Bio Europe Clontech, France) and the packaging
cell line (GP2, Hek293) retroviral particles carrying recombinantWT or
mutatedMLC1 (S246R, S280L, C125R)were generated as previously de-
scribed (Lanciotti et al., 2012). By infection with recombinant retroviral
particles, astrocytoma cell lines overexpressing WT and mutated MLC1
and a control cell line infected with the empty virus were generated, as
previously described (Lanciotti et al., 2012). Cells were exposed to
hyposmotic solution, as described previously (Brignone et al., 2011).
Cells stimulated with 100 nM baﬁlomycin A1 (Sigma-Aldrich,
St. Louis, MO) in serum-free (SF) medium for 3, 6 and 48 hours (h)
were used for immunoﬂuorescence stainings and western blot analysis
as described below. The procedures for human monocyte isolation and
culture are described in the Supplementary material.Immunoﬂuorescence and confocal microscopy analysis
Astrocytoma cells grown on polylysine-coated coverslips were incu-
bated in isosmotic, hyposmotic or baﬁlomycin-containing solution for
different time lengths, ﬁxed for 10 minutes (min) with 4% paraformal-
dehyde and washed with PBS. After 1 h of incubation with blocking
solution (5% BSA in PBS), cells were incubated for 1 h at room tempera-
ture (RT) with the following primary antibodies (Abs) diluted in PBS
containing 0.025% Triton X100: afﬁnity puriﬁed anti-MLC1 polyclonal
Ab (pAb) (1:50, Atlas AB, AlbaNova University Center, Stockholm,
Sweden), anti-V-ATPase B2 monoclonal Ab (mAb) (D11; 1:50, Santa
Cruz Biotechnology, Inc., Santa Cruz, CA), anti-EEA1 mAb (1:50, BD
Transduction Laboratories, Lexington, KY), anti-Rab5 mAb (D11; 1:25,
Santa Cruz Biotechnology), anti-Rab11 mAb (clone47; 1:25, Millipore,
Temecula, CA), anti-Lamp-2 mAb (1:100, Abcam, Cambridge, UK),
anti-transferrin receptor (TfR) mAb (1:80, Abcam) and anti-TRPV4
(H-79) pAb (1:10, Santa Cruz Biotechnology). As secondary Abs, a
biotinylated goat anti-rabbit IgG H + L Ab (4.3 μg/ml; Jackson
Immunoresearch Laboratories, West Grove, PA) followed by
streptavidin-TRITC (2 μg/ml; Jackson), and Alexa Fluor 488 goat anti-
mouse IgG Ab (1:300, Invitrogen, Milan, Italy) were used. Coverslips
were washed, sealed in Vectashield medium (Vector Lab, Burlingame,
CA) and analyzed with a laser scanning confocal microscope (LSM 5
PASCAL, Carl Zeiss, Jena, Germany). In the colocalization experiments
ﬂuorescence intensity proﬁles or ﬂuorochrome colocalization analysis
based on Manders' overlap coefﬁcient (MOC, Manders et al., 1993)
was evaluated with the proﬁle analysis tool of the LSM 5 PASCAL or
NIH ImageJ software. MOC value range is 0–1 (0: no colocalization, 1:
all pixels colocalize).Immunostaining of human brain tissue
Post-mortem brain tissue from a person without neurological dis-
ease was obtained from the UK MS Tissue Bank at Imperial College
London, and stained as previously described (Brignone et al., 2011).
Brieﬂy, sections were incubated overnight (ON) at 4 °C with a mixture
of rabbit anti-MLC1 pAb (1:250, ATLAS) and anti-V-ATPase B2 mAb
(D11) (1:100, Santa Cruz Biotechnology) or anti-GFAP mAb (1:20,
Pharmingen BD Biosciences, Milan, Italy). After extensive washings,
sections were incubated for 1 h at RT with a mixture of ﬂuorescein-
conjugated goat anti-mouse and rhodamine-conjugated goat anti-
rabbit Abs and images were analyzed with laser scanning confocal
microscope (LSM 5 PASCAL).
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Cytosolic andmembrane fractions from cultured astrocytes and total
protein extracts fromastrocytoma cell lineswere obtained as previously
described (Lanciotti et al., 2010, 2012). Equal amounts of proteins
(30 μg) were resolved on SDS-PAGE using gradient (4–12%) precasted
gels (Invitrogen), and transferred onto a nitrocellulose membrane. Ni-
trocellulose membranes were blotted ON at 4 °C using anti-MLC1 pAb
(1:1500, in-house generated; Ambrosini et al., 2008), anti-V-ATPase
A1 mAb (H-140;1:1000, Santa Cruz Biotechnology), or anti-TRPV4
pAb (1:200, Alomone Labs, Israel) in PBS/3% BSA followed by extensive
washings and then incubated for 1 h with horseradish peroxidase-
conjugated anti-mouse or anti-rabbit Abs (1:10000; Thermo Scientiﬁc,
MO), for 1 h at RT. Immunoreactive bands were visualized using an en-
hanced chemiluminescence reagent (Thermo Scientiﬁc), according to
the manufacturer's instructions, and exposed on X-ray ﬁlms. Densito-
metric analyses of WB bands were performed using ImageJ software.
Pull-down and LC–MS/MS analysis for the identiﬁcation of MLC1 protein
interactors
Cytosolic andmembrane protein extracts obtained from cultured rat
astrocytes were subjected to pull-down assay using recombinant His-
tagged MLC1 bound to Ni-NTA resin and control empty resin, as previ-
ously described (Ambrosini et al., 2008; Brignone et al., 2011; Lanciotti
et al., 2010, 2012). Proteins pulled-down with recombinant MLC1 and
control unspeciﬁc proteins eluted from control resin were separated
by SDS-PAGE, stained with Coomassie Colloidal Blue (Invitrogen) for
proteomic analysis and analyzed by RP-LC–MS/MS. Protein bands pres-
ent in eluates fromMLC1 resin but not in control empty resin were ex-
cised and destained with 50 mM ammonium bicarbonate/acetonitrile
(1:1 v/v) solution (Merck Darmstadt, Germany) and then dried by ace-
tonitrile treatment. Protein cysteine residues were reduced by 10 mM
dithiothreitol (Sigma-Aldrich Canada Markham, ON, Canada) in 50
mM ammonium bicarbonate (ICN Biomedicals Aurora, OH) for 45 min
at 56 °C, then alkylated by 55 mM iodoacetamide (Sigma-Aldrich) for
30min in the dark at RT in 50mMammoniumbicarbonate. Finally, sam-
ples were dried by centrifugation under vacuum and in-gel digestion
was performed by incubating gel particles with 12.5 ng/ml trypsin
(sequencing grade modiﬁed porcine trypsin, Promega, Madison, WI)
in 25 mM ammonium bicarbonate at 37 °C ON under stirring. Peptide
mixtureswere analyzed by nanoﬂow reversed-phase liquid chromatog-
raphy tandem mass spectrometry (RP-LC–MS/MS) using an HPLC Ulti-
mate 3000 (DIONEX, Sunnyvale, CA) connected on line with a linear
Ion Trap (LTQ, Thermo Electron, San Jose, CA). Peptides have been
desalted in a trap column (Acclaim PepMap 100 C18, LC Packings,
DIONEX) and then separated in a reverse phase column, a 10-cm long
fused silica capillary (Silica Tips FS 360-75-8, New Objective, Woburn,
MA), slurry-packed in-house with 5 μm, 200 Å pore size C18 resin
(Michrom BioResources, CA). Peptides were eluted using a linear gradi-
ent from 96% A (H2Owith 5% acetonitrile and 0.1% formic acid) to 60% B
(ACNwith 5% H2O and 0.1% formic acid) for 40 min, at 300 nl/min ﬂow
rate. Analyses were performed in positive ion mode and the HV Poten-
tial was set up around 1.7–1.8 kV. Full MS spectra ranging fromm/z 400
to 2000 Da were acquired in the LTQ mass spectrometer operating in a
data-dependent mode in which each full MS scan was followed by ﬁve
MS/MS scans where the ﬁve most abundant molecular ions were dy-
namically selected and fragmented by collision-induced dissociation
(CID) using a normalized collision energy of 35%. Target ions already
fragmentedwere dynamically excluded for 30 s. Tandemmass spectra
were matched against a database containing rat proteins
downloaded from Swiss Prot (http://www.uniprot.org/downloads)
and through SEQUEST algorithm incorporated in Bioworks software
(version 3.3, Thermo Electron). The parameters for the database search
were: fully tryptic cleavage constraints, with the possibility to have one
miss cleavage permitted, static carbamidomethylation on cysteineresidues and methionine oxidation as variable modiﬁcation. Data were
searched with 1.5 Da and 1 Da tolerance respectively for precursor and
fragment ions. A peptide has been considered legitimately identiﬁed
when it achieved cross correlation scores of 1.8 for [M + H]1+, 2.5 for
[M + 2H]2+, 3 for [M + 3H]3+, and a peptide probability cut-off for
randomized identiﬁcation of P b 0.001.
Co-puriﬁcation of histidine-tagged MLC1 interactors
Lysates obtained from three 175 cm2 ﬂasks of conﬂuent astrocytoma
cell lines stably overexpressing histidine-tagged WT or mutated MLC1
(U251-HisMLC1) and control cells infected with empty viral vectors
were incubated ON at 4 °C with 100 μl (50% v/v suspension) of Ni-
NTA Agarose (Qiagen, Hilden, Germany). After extensive washings (10
bed volumes of 10 mM–25 mM imidazole, 0.2% Triton X-100, 0.15 M
NaCl, 20 mM Tris–HCl pH 7.4), protein elution was carried out using
imidazole at a concentration of 50 and 200 mM (Lanciotti et al., 2010).
The eluted proteins were analyzed by SDS-PAGE and WB.
Cell surface protein biotinylation and isolation
Four 75 cm2 ﬂasks of 90–95% conﬂuent U251 astrocytoma cell lines
overexpressingWTor S280LMLC1, untreated or treated for 30minwith
hyposmotic solution as previously described (Brignone et al., 2011),
were incubated with Sulf-NHS-SS-Biotin (0.25 mg/ml, Thermo Scientif-
ic, Rockford, IL) for 30min at 4 °C. The biotinylation reactionwas termi-
nated by the addition of 500 μl of Quenching solution (Thermo
Scientiﬁc) per ﬂask. Following biotinylation, the cells were harvested
and solubilized in Lysis Buffer (Thermo Scientiﬁc). The cells were
further disrupted by brief sonication and centrifuged for 2 min at
10,000 ×g. Solubilized biotinylated membrane proteins were incubated
for 60 min at room temperature with NeutrAvidin® Agarose
(Thermo Scientiﬁc) in column, as indicated by the manufacturer.
The NeutrAvidin® Agarose bound biotinylated proteins were eluted
from the column with 450 μl SDS-PAGE Sample Buffer (62.5 mM Tris–
HCl, pH6.8, 1% SDS, 10% glycerol, 50 mM DTT). Fractions containing
eluted protein were analyzed by Western Blot, as described above.
Endosomal pH measurement by FITC-dextran
Endosomal pH was measured by means of the video-imaging tech-
nique with the pH sensitive probe FITC-dextran. FITC-dextran (Sigma-
Aldrich) loading was achieved by exposing astrocytoma cells grown
on glass coverslips for 30 min to a loading solution with the following
composition (mM): 122 NaCl, 3.3 KCl, 1.2 KH2PO4, 1.3 CaCl2, 1 MgCl2,
10 D-glucose, 25 NaHCO3, 0.07 FITC-dextran (70 KD) (37 °C, CO2 5%,
pH 7.4). The short incubation period in a bicarbonate buffered solution
allowed the endocytosis of FITC-dextran and the formation of vesicles in
which the control of physiological luminal pH was made possible. After
a strong wash out to remove unspeciﬁcally bound probe, the glass
coverslip was placed in a stainless steel chamber (Attoﬂuor cell cham-
ber,Molecular Probes, Invitrogen)positioned on the stage of an inverted
microscope (Axiovert 35, Zeiss, Germany), and bathed in an extracellu-
lar solution similar to the loading solution with HEPES replacing
NaHCO3. During recording, FITC-dextran loaded cells were exposed
every 2 s to the excitation wavelengths of 480 and 440 nm by means
of a monochromator (Polychrome II, Photonics, Germany), and the
emission light at 510 nm was collected by a 40× (1.35 NA) UApo/340
oil immersion objective (Olympus, Japan) and recorded by a CCD
camera (PCO, Sensicam, Germany). This allowed the recording of
1280 × 1024 pixels/frame with spatial resolution of 170 nm/pixel. A
local perfusion system (Rapid Solution Changer 100; Biologic) allowing
the rapid switch between different solutions was used. After a 60 s
period of recording in the extracellular solution, the cells were bathed
with aKCl-based calibration solution containing the ionophore nigericine
(10 μM) at pH 7.5 and 6.5, each for 60 s. The calibration solution had the
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glucose and 10 HEPES buffer. The ratios of the ﬂuorescence intensity
values at 480 nm and 440 nm were converted to pH values by linear
regression ﬁtting to the line obtained with the calibration pH values 7.5
and 6.5. The pH value of the single FITC-dextran-containing endosomal
vesicles was calculated from the average pH recorded in the extracellular
solution. Recording and analysis of the data were made possible by the
use of the Imaging Workbench software package (INDEC Systems, CA).
For further data processing and presentation the Origin 7.5 software
package (Microcal software, USA) was utilized. Data are shown as
mean ± SEM values of pH values, and statistical signiﬁcance was calcu-
lated using the Student's t-test.Transferrin (Tf) internalization and recycling assay
Transferrin internalization and recycling assay was performed as
previously described (Bacac et al., 2011), with minor modiﬁcations.
Brieﬂy, subconﬂuent U251 astrocytoma cells grown on polylysine-
coated glass coverslips were washed twice with PBS and then starved
for 2 h in internalization medium (IM) (DMEM, 0.01% BSA) to deplete
endogenous transferrin. Where indicated, hyposmotic cell treatment
was performed as previously described (Brignone et al., 2011). Then,
cells were cooled on ice for 5 min to block endocytosis, rinsed using
ice-cold PBS, and incubated with ice-cold IM containing human trans-
ferrin conjugated to Alexa Fluor 488 (50 μg/ml, Molecular Probes,
Invitrogen) for 1 h at 4 °C to allow cell-surface binding of transferrin.
Cells were then washed on ice using cold PBS–BSA 0.5% to remove
unbound transferrin, and the probe was chased at 37 °C for indicated
time-periods in the presence of 100× excess unlabeled iron saturated
human holo-transferrin (Sigma-Aldrich) to prevent ﬂuorescent trans-
ferrin re-internalization. At the end of each time-point, cells grown on
coverslips were ﬁxed on ice using 4% PFA and analyzed using a laser
scanning confocal microscope (LSM 5 PASCAL).Results
MLC1 interacts with proteins involved in endosomal pH regulation
A proteomicMS/MS analysis ofMLC1molecular interactorswas per-
formed on cytosolic and membrane protein fractions from rat primary
astrocytes that were pulled down with recombinant His-tagged-MLC1
protein bound to NiNTA resin selectively linking histidine residues
(see Materials and methods). Among the potential MLC1 interactors
identiﬁed (manuscript in preparation), we found that 2 subunits
(a1 and B2) of vacuolar ATPase (V-ATPase), the proton pump responsi-
ble for endosomal acidiﬁcation (Forgac, 2007), were pulled-down by
His-MLC1 in 2 out of 3 experiments (Table 1). In the same experiments
we also detected the alpha and beta subunits of the Na, K-ATPase
pump (Table 1), thus conﬁrming the results obtained in rat astrocytes
and human astrocytoma cells using the yeast two-hybrid system and
biochemical assays (Brignone et al., 2011; Lanciotti et al., 2012). Because
Na, K-ATPase, besides controlling plasma-membrane potential and cell
volume, is also involved in the regulation of endosomal pH (FuchsTable 1
MLC1 protein interactors identiﬁed by mass spectrometry in the membrane protein extracts d
Protein name Short name Probab
V-type proton ATPase 116 kDa subunit a isoform 1 VPP1 1.64E −
V-type proton ATPase subunit B, brain isoform VATB2 1.21E −
Sodium/potassium-transporting ATPase subunit alpha Atp1a1 2.10E −
Sodium/potassium-transporting ATPase subunit beta AT1B3 2.48E −
Probability corresponds to the Sequest probability score deﬁned as the probability that the pept
(probability). % Seq Cov indicates thepercentage of the protein sequence covered bymatchingp
in the protein. MW is for Molecular Weight and is expressed in kDa. In the last column the nuet al., 1989), these ﬁndings suggested that MLC1 might play a role in
this process.
Using a mAb recognizing the a1 subunit of V-ATPase, the interaction
between MLC1 and V-ATPase was conﬁrmed by WB analysis of proteins
pulled-down from rat primary astrocytes, particularly in the membrane
protein fraction (Fig. 1a). V-ATPase also co-puriﬁed with His-tagged WT
MLC1 over-expressed in a human astrocytoma cell line (Fig. 1b). In
astrocytoma cell lines overexpressing 3 MLC1 missense mutations
(S246R, S280L and C125R) (Lanciotti et al., 2012), the amount of V-
ATPase associated with MLC1 was markedly lower than in WT MLC1 as-
trocytoma cells (Figs. 1b, c), indicating that each of these pathologicalmu-
tations affects MLC1 molecular interactions. Double immunostaining for
MLC1 and V-ATPase revealed that in WT MLC1 astrocytoma cells MLC1
and V-ATPase colocalized in perinuclear vesicles (Fig. 1d, arrows;
colocalization analysis, as described in theMaterials andmethods section,
is shown in Fig. S1). In post-mortemhuman brain tissue V-ATPase immu-
noreactivity was detected in cytoplasmic vesicles of GFAP+ astrocytes
(Fig. 1e, arrows in magniﬁcation) and in astrocytic end-feet surrounding
blood vessels where it colocalized with MLC1 (Fig. 1f, arrows in magniﬁ-
cation). Altogether, these ﬁndings suggest that in astrocytes MLC1 might
interact with V-ATPase in intracellular organelles.MLC1 localization in speciﬁc endosomal compartments and effects of
pathological mutations
We (Lanciotti et al., 2012) and others (Duarri et al., 2008) have pre-
viously shown that the 3 MLC1 missense mutations analyzed here dif-
ferently affect MLC1 intracellular localization. Similarly to WT MLC1,
the S246R mutated protein reaches the plasma membrane, while the
S280L and C125R mutations cause intracellular retention of MLC1 pro-
tein (Lanciotti et al., 2012) (see also Figs. 1a–d). To understandwhether
pathological mutations could affectMLC1 localization andmolecular in-
teractions in the cytoplasmic vesicular compartment, astrocytoma cell
lines overexpressing WT or mutated MLC1 were immunostained with
anti-MLC1 Ab in combination with Abs speciﬁc for endosomal markers.
Double immunostainings for MLC1 and EEA1 or Rab5, two proteins
expressed in organelles of the early endosomal compartment (Jovic
et al., 2010), revealed that WT MLC1 colocalized with both markers
(Figs. 2a and e, respectively). When using Abs to proteins expressed in
the recycling (Rab11) and late endosomal-lysosomal (Lamp-2) com-
partments, we observed that WT MLC1 immunoreactivity largely
colocalized with Rab11+ recycling endosomes (Fig. 2i) and to a much
lesser extent with Lamp-2+ organelles (Fig. 2m).While the distribution
of S246Rmutant protein in intracellular organelleswas similar to that of
WT MLC1 (Figs. 2b, f, j, n), lower amounts of S280L and C125R mutants
were found in EEA1, Rab5+ and Rab11+ organelles when compared to
WTMLC1. Conversely, the samemutant proteinsweremore abundantly
localized in Lamp-2+ organelles relative to the WT protein (Manders'
colocalization coefﬁcient and statistical analysis is shown in Fig. S2).
To summarize, this set of experiments allowed us to conclude that
intracellular MLC1 is expressed mainly in the early endosomal and
Rab11+ recycling compartments and that pathological mutations can
affect both MLC1 membrane localization and MLC1 distribution in spe-
ciﬁc endosomal compartments.erived from rat astrocytes.
ility Seq Cov % MW (kDa) Accession n Peptides n
06 4 96 P25286 2
06 11 57 P62815 3
11 19 113 P06685 6
09 17 32 Q63377 3
ide assignment is a randommatch to the spectral data: the value is reported as−10 ∗ log
eptides based on thenumber ofmatching amino acids over the total number of aminoacids
mber of peptides mapped for each identiﬁed protein is reported.
Fig. 1. Interaction betweenWTMLC1 andV-ATPase. a. Pull-down assay shows the interaction betweenMLC1 andV-ATPase (a1 subunit) in rat primary astrocytes. Cytosolic andmembrane
fractions from primary cultures of rat astrocytes (input) were pulled-down by His-MLC1 and His-empty vector (used as control) bound to NiNTA-agarose and eluted with 0.1 M glycine,
pH 3. Western blot (WB) analysis shows that V-ATPase interacts with His-MLC1 in both the cytoplasmic (cyt) and membrane (mem) fractions. A very low level of unspeciﬁc binding is
observed only in the membrane fraction of the NiNTA-agarose bound with His empty vector. Molecular weight markers are indicated on the left (kDa). b. His co-puriﬁcation assay was
performed to verify the association between MLC1 and V-ATPase in human astrocytoma cells (U251) overexpressing His-tagged WT and mutated MLC1. V-ATPase is co-eluted and
enriched with 200 mM imidazole from NiNTA-agarose bound with proteins of WT MLC1 astrocytoma (WT). A decrease in the binding is observed when MLC1 S246R, C125R and
S280L NiNTA-agarose samples have been used, while no interaction is detected using samples derived from astrocytoma cells infectedwith empty vector (used as control). One represen-
tative experiment out of 3 performed is shown. Molecular weight markers are indicated on the left (kDa). c. Densitometric analysis of V-ATPase protein bands revealed by WB in (b). d.
Double immunoﬂuorescence staining of astrocytoma cells overexpressing WT MLC1 with anti-MLC1 pAb (red) and anti-V-ATPase mAb (green) reveals colocalization of MLC1 and V-
ATPase in intracellular vesicles, mainly in perinuclear areas (arrows). e. Immunoﬂuorescence staining of normal human brain tissue with GFAP mAb (green) and anti-V-ATPase pAb
(red) shows V-ATPase expression in intracytoplasmic vesicles of GFAP+ astrocytes (arrows in the microscopic ﬁeld shown at high power magniﬁcation on the right). f. Immunoﬂuores-
cence staining of normal human brain tissue with anti-MLC1 pAb (red) and anti-V-ATPasemAb (green) reveals that MLC1 and V-ATPase colocalize in perivascular astrocyte end-feet (ar-
rows in the microscopic ﬁeld shown at high power magniﬁcation on the right). Scale bars: 10 μm.
5M.S. Brignone et al. / Neurobiology of Disease 66 (2014) 1–18To exclude that MLC1 distribution in early and recycling organelles
and the effects of MLC1 mutations observed in astrocytoma cells were
due to tumor cell-speciﬁc trafﬁcking pathways and/or overexpression
of recombinant proteins we analyzed the distribution of endogenous
MLC1 in blood monocyte-derived macrophages (Boor et al., 2005;
Duarri et al., 2008; Petrini et al., 2013) that were obtained from healthy
donors and MLC patients. In macrophages from healthy donors MLC1
immunoreactivity was present in the cell membrane, the endoplasmic
reticulum cisternae and intracellular vesicles where it colocalized with
Rab11 and EEA1 (Figs. S3a,d). In macrophages from two MLC pa-
tients, each carrying a different MLC1 mutation (see Materials and
methods), MLC1 immunoreactivity was almost undetectable in theplasma membrane, as previously reported (Petrini et al., 2013), and
showed reduced colocalization with cytoplasmic organelle markers,
particularly with Rab11 (Figs. S3b,c,e,f).
MLC1 trafﬁcs through the Rab11+ perinuclear recycling compartment
The data presented above indicate that MLC1 is abundantly dis-
tributed in perinuclear vesicles, mainly in Rab11+ organelles. Since
Rab11+ perinuclear organelles are part of the perinuclear (or
pericentrosomal) recycling compartment (PNRC) which is important
for slow recycling of proteins and storage of membrane proteins, in-
cluding ion and water channels (Mukherjee et al., 1997; Sheff et al.,
Fig. 2. Intracellular localization of WT andmutatedMLC1 in human astrocytoma cell lines. a–d. Double immunoﬂuorescence staining for MLC1 (red) and early endosome antigen (EEA1)
(green) shows colocalization of MLC1 and EEA1 in the perinuclear area of MLC1-WT (a) and S246Rmutant (b) astrocytoma cells but not of S280L (c) and C125R (d) mutant astrocytoma
cells. e–h. Double immunoﬂuorescence for MLC1 (red) and Rab5 (green) reveals protein colocalization in WT (e) and S246R (f) MLC1 astrocytoma cells, but only occasionally in
S280L (g) and C125R (h) mutants. i–l. Double immunoﬂuorescence for MLC1 (red) and Rab11 (green) shows that WT (i) and S246R (j) MLC1 proteins are abundantly present in
Rab11+ recycling endosomes while colocalization is markedly reduced in S280L (k) and C125R (l) mutants. m–p. Double immunoﬂuorescence for MLC1 (red) and the lysosomal
marker Lamp-2 (green) reveals a partial colocalization in WT (m) and mutated MLC1 expressing astrocytoma cells (n–p). Note that Rab5 and Rab11 immunoreactivities have a
more diffuse intracellular distribution in WT and S246R MLC1 astrocytoma cells compared to S280L and C125R mutants. Scale bars: 10 μm.
6 M.S. Brignone et al. / Neurobiology of Disease 66 (2014) 1–181999; Ullrich et al., 1996), we investigated trafﬁcking of MLC1 through
this compartment. In WT MLC1 astrocytoma cells MLC1 localization in
PNRC was conﬁrmed by the ﬁnding that MLC1 immunoreactivity over-
lapped with that of the transferrin receptor (TfR), which is speciﬁcallyexpressed in Rab11+ organelle (Presley et al., 1997; Ullrich et al.,
1996) (Fig. 3, colocalization analysis is shown in Fig. S4).
To study MLC1 recycling through the PNRC WT MLC1 astrocytoma
cells were treated with baﬁlomycin, a speciﬁc inhibitor of V-ATPase
Fig. 3.WTMLC1 is localized in the perinuclear recycling compartment (PNRC). Double immunoﬂuorescence staining of WT MLC1 astrocytoma cell lines with anti-MLC1 pAb (red) and
anti-transferrin receptor mAb (TfR; green), known to localize in PCRN, shows overlap of MLC1 and TfR immunoreactivities in the perinuclear area (arrows). Scale bar: 10 μm.
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recycling to the cell membrane through PNRC without affecting TfR en-
docytosis and transport to the perinuclear compartments (Baravalle
et al., 2005; Presley et al., 1993, 1997). Incubation of astrocytoma cells
with 100 nM baﬁlomycin for 3, 6 and 48 h induced a progressive disap-
pearance ofWTMLC1 from the plasmamembrane and its accumulation
in Rab11+ vacuolar structures, as revealed by double immunostaining
with anti-MLC1 and anti-Rab11 Abs (Fig. 4a). After 48-h stimulation
all the membrane-associated MLC1 were recruited, along with TfR, to
Rab11+ cytoplasmic organelles (Fig. 4b). These structures appeared
morphologically swelled due to defective acidiﬁcation, as already de-
scribed in other baﬁlomycin-treated cells (Bacac et al., 2011; Baravalle
et al., 2005).
When MLC1 mutant expressing astrocytoma cells were analyzed
after baﬁlomycin treatment we found that, similarly to WT MLC1, the
plasma membrane-associated S246R protein accumulated in Rab11+
intracellular organelles (data not shown). Conversely, no accumulation
of themutant S280L and C125R proteins, which fail to reach the plasma
membrane, was observed in TfR+ or Rab11+ organelles (Figs. S5a,b).
UsingWB tomonitorMLC1 protein levels we found that 48-h treatment
with baﬁlomycin caused accumulation of the membrane-associated
dimeric form of WT MLC1 and S246R proteins and a decrease of S280L
and C125R mutants (Fig. S6a). Since baﬁlomycin did not increase
MLC1 mRNA in WT MLC1 astrocytoma cells (Fig. S6b), accumulation
of WT MLC1 and S246R mutant is likely caused by blockade of protein
degradation consequent to baﬁlomycin-induced arrest of lysosomal
function, as previously reported (Baravalle et al., 2005). In contrast,
since S280L and C125Rmutants aremainly retained in the endoplasmic
reticulum (ER), their decrease may be caused by ER associated protein
degradation (ERAD) (Duarri et al., 2008), which is unaffected by
baﬁlomycin treatment (Ishida et al., 2009). To summarize, these data in-
dicate that, similarly to some water and ion channels (McEwen et al.,
2007; Takata, 2006; Takata et al., 2008; Van de Graaf et al., 2006,
2008), in astrocytoma cells MLC1 trafﬁcs between the plasma mem-
brane and Rab11+ organelles of the PNRC.
Hyposmosis stimulates MLC1 recycling to the plasma membrane
MLC1 recycling and the effect of pathological MLC1 mutations
on this process were analyzed in hyposmotic conditions that in
primary rat astrocytes favor MLC1 transport to the plasma membrane
(Brignone et al., 2011; Lanciotti et al., 2012). To this end, MLC1 distribu-
tion in the recycling endosomal compartment was analyzed by immu-
nostaining of astrocytoma cells expressing WT or mutated MLC1 with
anti-MLC1 and anti-Rab11 Abs in basal conditions and after incubation
in hyposmotic solution. A progressive increase inmembrane expression
of WT MLC1 was observed between 5 and 30 min after exposure to
hyposmotic solution, leading to strong labeling of membranes in astro-
cytic end-feet and thin ﬁllopodia and at astrocyte–astrocyte contacts in
the majority of MLC1+ cells (Figs. 5a,b). Hyposmotic treatment alsoinduced intracellular redistribution of Rab11+ vesicles from their typi-
cal perinuclear localization throughout the cell body and cytoplasmic
extensions where they colocalized with MLC1 (Fig. 5b). This result
was conﬁrmed by analysis of the ﬂorescence intensity proﬁle of double
stained MLC1+/Rab11+ cells (Figs. 5c,d) and by WB quantitation of
hyposmosis-induced translocation of WT MLC1 to the plasma mem-
brane using enriched plasma membrane protein fractions obtained
after selective biotinylation of cell surface proteins (Fig. 5e). Interest-
ingly, in the same experiments we found that only the dimeric
form of MLC1 (60 kDa) is expressed at the plasma membrane
after hyposmotic stress while the monomeric MLC1 component
(36 kDa) is not detectable anymore (Fig. 5e), conﬁrming that
MLC1 dimerization is important for MLC1 functionality (Brignone
et al., 2011).
In contrast, hyposmotic treatment did not induce plasma mem-
brane translocation of the S280L MLC1 mutant protein, representa-
tive of MLC1 mutants not expressed in the plasma membrane, as
revealed by both immunoﬂuorescence staining and WB analysis of
biotinylated proteins (Figs. S7a,b). Immunoﬂuorescence staining of
S246R MLC1 astrocytoma cells showed that, similar to WT MLC1,
this mutant protein is expressed at the plasma membrane already
in control conditions but that its membrane localization does not in-
crease after 30-min incubation in hyposmotic solution (Fig. S8).
Since hyposmosis did not alter MLC1 mRNA levels (Fig. S9) these re-
sults demonstrate that the increase in plasma membrane expression
of MLC1WT induced by hyposmotic stress is mainly due to mobiliza-
tion from intracellular organelles, primarily belonging to the Rab11+
PRNC. The hyposmosis-induced recycling process is hampered by
pathological MLC1 mutations, independently of whether the mutat-
ed MLC1 protein localizes in the plasma membrane in isosmotic
conditions.
MLC1 is involved in the regulation of early endosome pH
MLC1 interaction with proteins involved in the regulation of
organelle acidiﬁcation, like V-ATPase and Na, K-ATPase, and the high
levels of expression of MLC1 in early and recycling endosomal compart-
ments support the idea of a possible involvement ofMLC1 in endosomal
function and modulation of organelle acidity. To assess organelle pH in
astrocytoma cell lines, we took advantage of the pH-sensitivity of FITC
ﬂuorescence emission in dynamic imaging experiments. After 30-min
incubation of astrocytoma cells in the presence of FITC-conjugated
dextran (see Materials and methods), endocytic vesicles containing
the dye could be observed as ﬂuorescence emitting dots. These were
mainly localized around the cell nucleus, which was visualized with
the chromatin selective dye Hoechst 33258 (Figs. 6a,b), and often clus-
tered on one side of the nucleus.
As expected, membrane permeabilization induced by the ionophore
nigericine revealed the pH sensitivity of most FITC-dextran loaded
vesicles. When the pH of FITC-dextran loaded vesicles was tested in
Fig. 4. Effect of baﬁlomycin on WT MLC1 protein localization and expression. a. Double immunoﬂuorescence stainings for MLC1 (red) and Rab11 (green) were performed in WT MLC1
astrocytoma cells that were grown in basal culture conditions (CTR) or treated with 100 nM baﬁlomycin (BAF) for 3, 6 and 48 h. Note the progressive disappearance of MLC1 from the
plasma membrane and concomitant accumulation of the protein in Rab11+ intracellular vacuolar structures. b. Double immunostaining for MLC1 (red) and transferrin receptor
(TfR, green) shows that after 48-h treatment with 100 nM baﬁlomycin, all MLC1 proteins colocalize with TfR in intracellular vacuolar structures. Scale bars: 10 μm.
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overexpressing astrocytoma cells, large variations in pH values were
calculated within a single cell (data not shown), suggesting
heterogeneity of endocytic vesicles. Interestingly, endocytic vesicles of
WT MLC1 astrocytoma cells had a more basic pH (6.76 ± 0.05) while
those of cells expressing the S280L and C125Rmutants had amore acidic
pH (6.37 ± 0.04 and 6.36 ± 0.05, respectively) compared to mock in-
fected control cells (6.49 ± 0.03). The pH value of endocytic vesicles of
S246R mutant astrocytoma cells (6.50 ± 0.02) was undistinguishable
from that of control cells (Figs. 6c,d). These ﬁndings indicate that WT
MLC1 overexpression increases endosomal pH and that this effect is
not reproduced by overexpression of mutated MLC1.
To understandwhether a speciﬁc endosomal compartment is affected
by MLC1-induced changes in vesicular pH, WT MLC1 astrocytoma cells
pre-loaded for 30 min with FITC-dextran (as described above) were
stained with anti-MLC1 Ab and Abs to speciﬁc organelle markers (Rab5,
EEA1, Rab11, Lamp-2). We observed that FITC-dextran mainly localized
in MLC1+ vesicles, in EEA1+ early endosomes (Figs. 7a,b, arrows) and,
to a lesser extent, in Rab5+ organelles (Fig. 7c, arrows). In the same
cells no colocalization was found between FITC-dextran and Rab11 or
Lamp-2 immunoreactivities (Figs. 7d and e, respectively), indicating
that the changes in organelle pH measured by FITC-dextran affect pre-
dominantly the EEA1+/Rab5+ early endosomal compartment.
In support of these ﬁndings, electronmicroscopy analysis of cytosolic
extracts derived from rat primary astrocytes (see Materials and
methods) conﬁrmed that MLC1 is abundantly expressed in the mem-
brane of EEA1+ organelles, in EEA1+ intraorganelle compartments and
in themembranes of Rab5+ vesicles (Fig. S10), a localization compatible
with a functional role of endogenous MLC1 in the early endosomal
compartment.
MLC1 overexpression increases transferrin and TRPV4 channel recycling
Because control of the luminal ionic composition of endolysosomal
vesicles is an essential regulatory step for protein sorting to the degra-
dative or recycling compartments (Grant and Donaldson, 2009; Luzio
et al., 2007) we next investigated whether MLC1 over-expression, by
altering endosomal pH, could inﬂuence protein trafﬁcking. Since WT
MLC1 overexpression induced a minor acidiﬁcation of early endosomes
(see above), a condition favoring protein sorting toward the recycling
pathway (Grant and Donaldson, 2009; Jovic et al., 2010; Yamashiro
and Maxﬁeld, 1987 and reference therein) we monitored protein
recycling in MLC1 overexpressing astrocytoma cells using a classical
assay based on the recycling properties of transferrin (Tf). This experi-
ment was performed in basal conditions and after hyposmotic stress
which favors MLC1 recycling to the plasma membrane, as shown
above. Astrocytoma cell lines expressingWTMLC1, S246R or S280Lmu-
tated proteins were incubated with Alexa Fluor 488-conjugated Tf at
4 °C to allow binding to surface TfR. After washing out the excess of
ﬂuorochrome-labeled Tf (T0), we further incubated the cells at 37 °C
for 20min and overnight in the presence of excess unlabeled Tf tomon-
itor Tf trafﬁcking. By comparing Tf-associated ﬂuorescence in WT and
mutant MLC1 astrocytoma cells at these different time points we did
not ﬁnd any appreciable difference in Tf trafﬁcking among cells express-
ingWT ormutated MLC1 in control conditions (data not shown). How-
ever, when MLC1 expressing astrocytoma cells were pre-incubated in
hyposmotic medium for 30 min to activate MLC1 recycling before incu-
bation with Alexa Fluor 488-conjugated Tf, we observed that compared
to T0, Tf-associated ﬂuorescence in WT MLC1 positive cells started to
decrease after 20 min (not shown) and disappeared almost completely
after overnight incubation, indicating extracellular release of Tf mole-
cules, as previously reported (Bacac et al., 2011; Takahashi et al.,
2012) (Figs. 8a,d). In contrast, a considerable amount of Tf-associated
ﬂuorescence was detectable in discrete intracellular aggregates in
S246R and S280L MLC1 astrocytoma cells after overnight incubation,
suggesting that WT but not mutant MLC1 accelerated Tf recycling(Figs. 8b,c,e,f). These results were conﬁrmed by ﬂuorescence intensity
analysis with confocal microscope (Fig. 8g).
The above ﬁndings prompted us to investigate whether MLC1 could
also inﬂuence the recycling of knownMLC1-interacting proteins.We fo-
cussed our attention on TRPV4 because, among the MLC1 interactors
identiﬁed so far, it is the only one for which a functional interaction
with MLC1 has been demonstrated (Lanciotti et al., 2012). Preliminary
experiments indicated that in WT MLC1 astrocytoma cells TRPV4 is
localized in Rab11+ perinuclear vesicles (Fig. S11). Using the Tf
recycling assay to analyze TRPV4 distribution in astrocytoma cells
during recycling we found that at T0 in WT MLC1 cells and in cells
carrying S280 MLC1 mutation TRPV4 had a similar distribution, mainly
in the cytoplasmic compartments where it partially colocalized with
Alexa Fluor 488-conjugated Tf (Figs. 9a,c). After 20min of Tf internaliza-
tion (data not shown) and particularly after overnight incubation
(Figs. 9b,d), TRPV4-Tf colocalization almost disappeared in WT-MLC1
astrocytoma cells but not in cells expressing the S280L mutant, where
TRPV4 still colocalized with Tf in discrete vesicles in the cell body and
cytoplasmic processes (Fig. 9d, arrows). These experiments suggest
thatWT andmutatedMLC1 can differently inﬂuence TRPV4 intracellular
localization and recycling. In order to verify whether TRPV4 recycling to
the plasma membrane was modulated by MLC1 expression we per-
formed biotinylation assays andWB analysis of cell surface proteins de-
rived from WT MLC1 and S280L overexpressing astrocytoma cells, in
control conditions and after hyposmotic stress. These experiments
showed that in WT MLC1+ cells low levels of TRPV4 were expressed
in theplasmamembrane in control conditions and that hyposmosis con-
sistently increased TRPV4 translocation to the plasma membrane. In
contrast, in mutant expressing astrocytoma cells TRPV4 was never
found among biotinylated surface proteins, neither in control nor after
hyposmotic stimulation (Fig. 9e). Overall, these results concur to dem-
onstrate that in astrocytoma cells WT, but not mutant MLC1, inﬂuences
TRPV4 trafﬁcking and plasma membrane expression.
Discussion
Understanding the functional role of MLC1 protein in astrocytes and
the effects ofMLC1mutations leading toMLC disease is an essential step
toward the identiﬁcation of disease mechanisms and the development
of effective therapies for patients affected by this rare childhood-onset
leukodystrophy. Using human astrocytoma cell lines stably overex-
pressing WT or mutated MLC1 proteins to study the localization and
function of MLC1 in endosomal organelles, we have uncovered a role
for MLC1 in pH regulation and protein trafﬁcking in the endocytic com-
partment and described the impact of pathological MLC1 mutations on
this pathway. Although of tumoral origin, this is a useful and reliable
experimental model to study the pathophysiological role of MLC1 as
the results obtained so far in human astrocytoma cells have been
reproduced in rat primary astrocytes and MLC patient-derived blood
cells (Lanciotti et al., 2010; and this study).
Intracellular MLC1 localizes in early and recycling endosomes and trafﬁcs
along the Rab11+ perinuclear recycling compartment
We have shown that WT MLC1, but not mutated MLC1 proteins
(C125R, S280L), which show defective plasma membrane localization,
is abundantly expressed in early endosomal organelles identiﬁed by
EEA1 and Rab5 markers (reviewed by Jovic et al., 2010; Maxﬁeld and
McGraw, 2004). Of interest, Rab5 also labels primary early endosomal
vesicles, both clathrin-coated vesicles (Zerial and McBride, 2001) and
caveolin-positive vesicles. The latter are responsible for caveolar-
dependent endocytosis (Aoki et al., 2007; Hagiwara et al., 2009) which
represents the main endocytosis route for MLC1 and its associated pro-
teins in astrocytes (Lanciotti et al., 2010) before their sorting to
EEA1+ endosomes (Fig. 10). In line with the present ﬁndings,
colocalization of MLC1 and EEA1 was detected in human brain tissue
10 M.S. Brignone et al. / Neurobiology of Disease 66 (2014) 1–18(Ambrosini et al., 2008). The present results indicate that MLC1 also
accumulates in perinuclear Rab11+ endosomal vesicles. The latter
deﬁne a speciﬁc intracellular compartment known as perinuclear
(or pericentrosomal) recycling compartment (PNRC) where manyproteins, including ion and water channels and receptors, are stored
and from where these molecules can be mobilized and recruited to
the plasma membrane in physiological conditions (Innamorati
et al., 2001; Mukherjee et al., 1997; Parent et al., 2009; Sheff et al.,
Fig. 6.WT and mutated MLC1 differently regulate endosomal pH. a,b. Fluorescence images of astrocytoma cells pre-loaded with FITC-dextran (green) and the chromatin selective dye
Hoechst 33258 (blue), to depict endosomes and nuclei, respectively. b. Higher magniﬁcation of the area selected in (a), depicting the polarized localization of FITC-dextran loaded
endosomes. Scale bar: 23 μm. c. The bar graph shows the mean ± SEM pH values in control astrocytoma cells infected with empty vector (CTR) and astrocytoma cells overexpressing
WT and mutated MLC1; the number of recorded cells for each cell line ranged between 43 and 83. Signiﬁcant differences between CTR and MLC1 overexpressing cells were calculated
using Student's t test; *Pb 0.05. d. The graph shows the time-course of pHchanges in labeled endosomesofWT and S280LMLC1 astrocytoma cells recorded in a representative experiment.
Note that the pH recorded in the time lag before the application of calibration solutions is more basic in WT compared to S280L MLC1 astrocytoma cells.
11M.S. Brignone et al. / Neurobiology of Disease 66 (2014) 1–181999; Takata et al., 2008; Ullrich et al., 1996). The ﬁnding that
hyposmosis increases the mobilization of Rab11+/MLC1+ vesicles
from perinuclear areas toward astrocytic plasma membrane and
end-feet suggests the presence of an intracellular pool of MLC1 that
is capable of recycling back to the cell surface in stress conditions.
We also observed accumulation of MLC1 in Rab11+ and TfR+ organelles
after astrocytoma cell treatment with the V-ATPase inhibitor
baﬁlomycin that selectively inhibits protein trafﬁcking along the
degradative-lysosomal pathway but not the transport of TfR to PNRC
(Baravalle et al., 2005). This ﬁnding conﬁrms Rab11+ vesicle-mediated
bidirectional trafﬁcking of MLC1 from the plasma membrane to the
PNRC and vice versa. Interestingly, in a previous study we observed
that also in rat primary astrocytes endogenous MLC1 was localized in
perinuclear vesicles and that treatment with nocodazole, a drug
which disrupts microtubule organization, abolished MLC1 perinuclear
accumulation (Lanciotti et al., 2010). Because microtubule disruptionFig. 5. Effects of hyposmotic stress onWTMLC1 intracellular trafﬁc. a,b. Astrocytoma cell lines o
for 30min and then stainedwith Abs toMLC1 (red) and Rab11 (green). In control cells (a)MLC1
it colocalizeswith Rab11+ vesicles (merge). Hyposmotic stress (b) induces amarked increase in
brane and at astrocyte-astrocyte contacts (asterisks), and the redistribution of Rab11+ vesicles a
d. Immunoﬂuorescence pixel intensity along the white dotted arrows drawn in representativ
hyposmotic stress, the ﬂuorescence intensity peaks of MLC1 and Rab11 re-distribute from the
peripheral cytoplasmic localization and toward the plasma membrane (arrows in d). A stron
red lines in c and d). e. WB of total cell proteins (Input) and of enriched surface proteins after b
(CTR) and (HYPO) hyposmotic conditions. Although hyposmotic stress does not affect the tota
amount of the dimeric (60 kDa) membrane-associated MLC1 component (CTR versus HYPO i
component is not detectable anymore. One representative experiment out of three performedaffects the perinuclear localization of Rab11+ vesicles and ofmembrane
proteins that undergo PNRC-mediated storage and recycling (Baravalle
et al., 2005; Vossenkämper et al., 2007), these ﬁndings suggest that also
in primary astrocytes endogenous MLC1 accumulates in this compart-
ment. In different cell types the presence of perinuclear pools of mem-
brane proteins has been reported to exert an important role in the
replenishment of the constitutively internalized proteins and for the
maintenance of steady-state surface levels of receptor and transporter
proteins like transferrin (Ullrich et al., 1996), thromboxane and dopa-
mine receptors (Li et al., 2012; Thériault et al., 2004), glucose trans-
porters (Ishiki and Klip, 2005; Widmer et al., 2005) ion and water
channels like Kv1.5 (McEwen et al., 2007), AQP2 (Nedvetsky
et al., 2007; Takata, 2006), TRPV5-6 (Van de Graaf et al., 2006,
2008) and junctional proteins, like E-cadherin (Balzac et al.,
2005) and claudin-1 (Dukes et al., 2011). By showing that
MLC1 is recycled through this pathway and that its recyclingverexpressingWTMLC1were incubated in control (CTR) or hyposmotic (HYPO) solution
immunoreactivity is found in the cellmembrane and in the perinuclear cytoplasm, where
MLC1 immunoreactivity throughout the cell body and processes, in the plasma cell mem-
long the astrocyte cell body and cytoplasmic extensions (arrowheads). Scale bars: 10 μm. c,
e cells in a and b was obtained using the proﬁle analysis tool of the LSM 5 PASCAL. After
central perinuclear area, typically observed in control conditions (arrow in c), to a more
g increase in MLC1 ﬂuorescence intensity is observed after hyposmotic stress (compare
iotinylation experiments (Eluate) fromWTMLC1 astrocytoma cells maintained in control
l amount of WT MLC1 protein (CTR versus HYPO in Input lanes), it strongly increases the
n Eluate lanes). Note that in the surface protein fraction the monomeric (36 kDa) MLC1
is shown. Molecular weight markers are indicated on the left (kDa).
Fig. 7.Characterization of FITC-dextran positive vesicles inWTMLC1 astrocytoma cells.WTMLC1 astrocytoma cellswere pre-loadedwith FITC-dextran for 30min to identify endosomes in
which pH changes have been recorded (see Fig. 6) and then labeled with anti-MLC1 Ab or Abs speciﬁc for endosomal organelles. a,b. MLC1 (red, a) and EEA1 (red, b) immunoreactivities
are found in FITC-dextran positive vesicles (green) (arrows). c. Immunostaining for Rab5 (red) reveals a slightly lower degree of localization in the FITC-dextran positive vesicles (green)
(arrows). d, e. No overlap is found between FITC-dextran (green) and Rab11 (red, d) or Lamp-2 (red, e) immunoreactivities. Scale bars: 10 μm.
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study unveils the importance of endosomal recycling in the reg-
ulation of MLC1 function and impairment of this process by
pathological MLC1 mutations.Localization of endogenous MLC1 in EEA1+ and Rab11+ organelles
and the effects of pathologicalmutations onMLC1 intracellular distribu-
tion were also observed in monocyte-derived macrophages from
healthy donors and MLC1 mutated patients. These ﬁndings allow us to
Fig. 8. Transferrin recycling assay in WT and mutant MLC1 astrocytoma cell lines after hyposmotic stress. Astrocytoma cell lines expressing WT MLC1, S246R or S280L mutated protein
were pre-incubated with Alexa Fluor 488-conjugated transferrin (Tf) at 4 °C to allow binding to surface TfR. After washing out labeled Tf (T0), cells were incubated at 37 °C overnight
(ON) in the presence of excess unlabeled Tf and then stained with anti-MLC1 Ab (red). a,b,c. Alexa Fluor 488-conjugated Tf (green) shows comparable binding to the surface of WT
and mutated MLC1 astrocytoma cells (T0). d,e,f. After overnight (ON) incubation with excess unlabeled Tf, Tf disappears almost completely from the surface of WT MLC1 astrocytoma
cells (d), whereas it is still present in S246R and S280L mutant astrocytoma cells (e,f). Scale bars: 10 μm. g. The bar graph shows the mean ± SEM values of the Alexa Fluor 488-
conjugated Tf ﬂuorescence intensity in the different astrocytoma cell lines after ON incubation; 10 to 15 random ﬁelds (ﬁeld area = 230 μm2) were analyzed. Signiﬁcant differences
between WT MCL1 and mutated (S246R, S280L) astrocytoma cells were calculated using Student's t test; *P b 0.05. **P b 0.005, ***P b 0.0005.
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WTMLC1 as well as the defects induced byMLC1mutations in astrocy-
toma cells might be due to MLC1 overexpression or to the tumoral
nature of the cells.
MLC1 is involved in the regulation of early endosome acidity
The identiﬁcation of V-ATPase and Na, K-ATPase, also known to
regulate early endosome pH, as proteins interacting with MLC1
(this study and Brignone et al., 2011, respectively) led us to hypothesize
a role for MLC1 in the control of organelle pH. FITC-dextran measure-
ment coupled with vesicle immunostainings revealed a decrease in
the acidiﬁcation of early endosomes (EEA1+ and Rab5+) in WT MLC1
astrocytoma cells compared tomock infected control cells. Importantly,
overexpression of all 3 pathological MLC1 mutants (S246R, S280L,
C125R) did not increase endosomal pH, indicating altered regulation
of this pathway in MLC disease. Because the S246R mutation does not
affect membrane expression of MLC1, these data suggest that reduced
MLC1 localization in the plasma membrane is not the sole indicator of
a pathological phenotype. Altogether, these data conﬁrm the hypothesisthat MLC1 is involved in the regulation of organelle acidity, possibly by
limiting vesicle acidiﬁcation. A similar behavior has been described for
the Na, K-ATPase which exerts an essential role in the maintenance of
the slightly acidic pH typical of early endosomes in which it is localized
(Cain andMurphy, 1988; Cain et al., 1989; Feldmann et al., 2007; Grabe
and Oster, 2001) and whose direct interaction with MLC1 has been
demonstrated by our group (Brignone et al., 2011). Future experiments
will aim to clarify the exactmechanisms throughwhichMLC1 can inﬂu-
ence endosomal pH and the molecular and functional relationships
between MLC1 and V-ATPase. Because it is known that abnormal acid-
iﬁcation can lead to endosome enlargement (Bacac et al., 2011;
Forgac, 2007; Martina et al., 2009), these data lead to the hypothesis
that the formation of intracellular vacuoles observed in MLC1 silenced
rat astrocytes and in astrocytes in the brain of MLC patients (Duarri
et al., 2011) might be due to endosome swelling caused by dysregula-
tion of organelle pH.
Themildly acidic pH of the endocytic pathway is strictly regulated by
a variety of ion channels, transporters and exchangers present in the
endosomalmembranes (Scott andGruenberg, 2011)where also endog-
enous MLC1 is localized (Fig. S10). Along with V-ATPase other proteins
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Fig. 10. Schematic representation of MLC1 intracellular trafﬁcking. A model of MLC1 intracellular trafﬁcking is proposed on the basis of our previous results (Lanciotti et al., 2010) and the
data presented in this paper. MLC1 is internalized via caveolae-mediated endocytosis and trafﬁcs through Rab5+ and EEA1+ early endosomes where it is sorted to the recycling or
degradative pathway. Most of the intracellular MLC1 protein is stored in the perinuclear Rab11+ recycling vesicles from which it is recycled to plasma membrane in stress condition
(Hyposmosis).
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the transient receptor potential (TRP) type, of the two pore (TPC) type
of calcium channels (Abe and Puertollano, 2011; Martina et al., 2009;
Morgan et al., 2011) and of the chloride channels, that mainly control
late/lysosomal compartment acidity (Edwards and Kahl, 2010;
Faundez and Hartzell, 2004). We cannot exclude that, in addition to
an effect on the activity of its molecular interactors (V-ATPase, Na,
K-ATPase), MLC1 may function itself as an ion channel and directly
inﬂuence organelle proton inﬂux.
MLC1 inﬂuences protein recycling
Early endosome organelles constitute the sorting station where the
fate of internalized proteins and lipids is decided by a complex interplay
of molecular and structural determinants mainly leading to changes in
intra-organelle pH (Jovic et al., 2010). There is broad evidence that the
acidiﬁcation of endocytotic vesicles is essential for the regulation of
uncoupling of receptor–ligand complexes, intracellular membrane
ﬂow and protein sorting toward the recycling or degradative pathway
(Jovic et al., 2010; Luzio et al., 2007) and that inhibition or overexpres-
sion of proteins involved in the regulation of endosomal pH affects pro-
tein trafﬁcking (Bacac et al., 2011; Hara-Chikuma et al., 2005; LelouvierFig. 9. TRPV4 recycling inWT and S280LMLC1 astrocytoma cell lines after hyposmotic stress. As
Alexa Fluor 488-conjugated Tf at 4 °C to allowbinding to surface TfR. Afterwashingout labeledT
unlabeled Tf and then stainedwith anti-TRPV4 pAb. a,c. TRPV4 (red) and Alexa Fluor 488-conju
astrocytoma cell plasmamembranes at T0. b,d. After ON incubationwith unlabeled Tf, TRPV4-T
cellswhere TRPV4 still colocalizeswith Tf in clustered intracytoplasmic vesicles (d, arrows). Scal
biotinylation (eluates) reveals that 30-min incubation in hyposmotic solution induces an increa
S280L mutation. Molecular weight markers are indicated on the left (kDa).and Puertollano, 2011; Martina et al., 2009; Smith and Lippiat, 2010).
Our experiments indicate that WT but not mutated MLC1 favors trans-
ferrin and TRPV4 channel recycling. The present results are in agree-
ment with a functional role of MLC1 in endosomal pH regulation,
since recycling vesicles are characterised by a slightly less acidic pH
compared to vesicles sorted toward the lysosomal degradative pathway
(Grant and Donaldson, 2009; Scott and Gruenberg, 2011). The demon-
stration that S280L and S246R MLC1 mutations do not promote trans-
ferrin and TRPV4 channel recycling supports the hypothesis that
pathogenic MLC1 mutations inﬂuence endosomal maturation and pro-
tein sorting decision.
We also show for the ﬁrst time that TRPV4 is expressed in Rab11+
perinuclear vesicles and is subjected to recycling pathway, as previously
reported for TRPV5 and TRPV6, two transient receptor cation channels
belonging to the same family of vanilloid-type of transient receptors
(Van de Graaf et al., 2006). The inﬂuence of MLC1 on the recycling
rate of its molecular partner TRPV4 could explain themolecular mecha-
nism underlying the functional effect of MLC1 on the TRPV4-mediated
calcium inﬂux that we have recently described (Lanciotti et al., 2012).
Defective TRPV4 recycling in hyposmotic conditions in MLC1 mutant
expressing astrocytoma cells could be responsible for a dysfunctional
astrocyte response to osmotic stress. The analysis of proteins exposedtrocytoma cell lines expressingWT ormutated S280LMLC1 proteins were incubatedwith
f (T0), cellswere incubated at 37 °C for 20min andovernight (ON) in the presence of excess
gated Tf (green) partially colocalize in intracellular vesicles inWTMLC1 and S280Lmutant
f colocalization disappears inWTMLC1 astrocytoma cells (b) but not in S280L astrocytoma
eBars:10 μm. e.WBof total cell proteins (input lanes) andof enriched surface proteins after
se in surface expression of TRPV4 inWTMLC1 astrocytoma cells but not in cells expressing
16 M.S. Brignone et al. / Neurobiology of Disease 66 (2014) 1–18on the cell surface in basal and hyposmotic conditions revealed a
marked reduction in plasmamembrane localization of TRPV4 inmutant
MLC1 expressing astrocytoma cells. Interestingly, defects in TRPV4
function have been recently reported to be responsible for cyst forma-
tion in the autosomal recessive polycystic kidney disease (Zaika et al.,
2013), suggesting that also in MLC disease cyst formation could be
caused by TRPV4 functional alterations. To date, TRPV4 is the only iden-
tiﬁedMLC1 interactorwhose activity ismodulated byMLC1 in rat astro-
cytes and human astrocytoma cells (Lanciotti et al., 2012). Recently,
mutations in the gene encoding Hepacam/Glialcam, an adhesion-like
molecule of unknown function, have been found in a considerable per-
centage (N50%) of MLC patients without mutations in MLC1 and
Hepacam/Glialcam protein has been reported to regulate speciﬁcally
MLC1 expression at astrocyte–astrocyte junctions (Duarri et al., 2011).
WB analysis and biochemical assays indicated that Hepacam/Glialcam
is expressed in astrocytoma cell lines and binds MLC1, and that MLC1
mutations differently affect this interaction (Lanciotti et al., 2012). Fur-
ther studies are needed to clarify MLC1-Hepacam/Glialcam interaction
in the astrocytoma cell model.Conclusion
This study shows that in astrocytes MLC1 is expressed in early
endosomes and recycled through the Rab11+ perinuclear compartment
(Fig. 10).MLC1 localization in the early endosomal compartment is func-
tionally relevant to modulate organelle acidity and protein recycling, in-
cluding recycling of the MLC1 interactor TVPR4, in stress conditions like
hyposmosis. It is possible that trafﬁcking of other MLC1 interacting pro-
teins, like Na, K-ATPase complex proteins and junction proteins [i.e. ZO-1
(Duarri et al., 2011)], is inﬂuenced by MLC1 and that dysregulation of
protein trafﬁcking following changes in brain homeostasis induces or
ampliﬁes brain damage in MLC patients carrying mutated MLC1 genes.
It is known that some junction proteins are continuously being
endocytosed and recycled back to the plasma membrane (Chalmers
andWhitley, 2012; Dukes et al., 2012) via caveolar-dependent internal-
ization and Rab11 recycling pathway (Desclozeaux et al., 2008; Dukes
et al., 2011; Nighot and Blikslager, 2012) and that their trafﬁc can be
modulated by the activity of ion channels responsible for endosomal
acidiﬁcation (Nighot and Blikslager, 2012). Abnormal recycling of junc-
tion proteins can lead to the formation of intracellular vacuoles (Dukes
et al., 2012) similar to those observed in the brain of MLC patients
(Duarri et al., 2011). We hypothesize that MLC1-mediated recycling be-
comes relevant when MLC1 is recruited to the plasma membrane due
to an increased functional demand of the astrocyte. In particular, reg-
ulation of MLC1 in the astrocyte membrane could be critical for the
astrocyte response to changes in extracellular osmolarity.
Endocytosis and recycling are essential processes in the regulation of
the expression of cell surfacemolecules thatmediate glial cell differentia-
tion and neuronal–glial interactions during brain development (Chen
et al., 2011; Shilo and Schejter, 2011; Yap andWinckler, 2012). Modiﬁca-
tion of these processes may result in brain oedema and disturbance of
myelin formation, which are observed also in other leukodystrophies as-
sociated with speciﬁc defects in astrocyte maturation and function
(Bugiani et al., 2011; Messing et al., 2012). By increasing our understand-
ing of the molecular mechanisms that lead to brain damage in MLC pa-
tients and could be shared with other leukodystrophies, this study
opens new perspectives for the identiﬁcation of therapeutic targets.Funding
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